Table 1 Patient characteristics.
Patient | Study population | SUD (All) | SUD (Recent) | COVID-19 | COVID-19 + SUD (All) | COVID-19 + SUD (Recent) |
|---|---|---|---|---|---|---|
Total | 73,099,850 | 7,510,380 | 722,370 | 12,030 | 1880 | 1050 |
Gender | ||||||
Female | 39,215,260 (54%) | 3,528,890 (47%) | 351,760 (49%) | 7160 (60%) | 920 (49%) | 510 (49%) |
Male | 33,388,310 (46%) | 3,972,450 (53%) | 366,960 (51%) | 4840 (40%) | 950 (52%) | 540 (51%) |
Unknown | 497,080 (1%) | 9040 (<1%) | 3640 (<1%) | 30 (<1%) | 10 (<1%) | 0 (0%) |
Age | ||||||
Adult (18–65) | 43,797,300 (60%) | 5,458,840 (73%) | 502,770 (70%) | 8180 (68%) | 1200 (64%) | 670 (64%) |
Senior (>65) | 17,810,980 (24%) | 2,034,850 (27%) | 217,380 (30%) | 3160 (26%) | 670 (36%) | 380 (36%) |
Junior (<18) | 10,547,380 (14%) | 21,970 (<1%) | 3670 (1%) | 700 (6%) | 10 (<1%) | 0 (0%) |
Race | ||||||
Caucasian | 40,065,790 (55%) | 5,505,640 (73%) | 525,560 (73%) | 5500 (46%) | 1050 (56%) | 610 (58%) |
African American | 7,523,880 (10%) | 1,206,150 (16%) | 144,950 (20%) | 5470 (45%) | 770 (41%) | 410 (39%) |
Asian | 1,184,420 (2%) | 63,610 (1%) | 5000 (1%) | 130 (1%) | 0 (0%) | 0 (0%) |
Hispanic/Latino | 1,055,220 (1%) | 69,790 (1%) | 5090 (1%) | 10 (<1%) | 0 (0%) | 0 (0%) |
Unknown | 8,995,110 (12%) | 832,070 (11%) | 65,090 (9%) | 530 (5%) | 150 (8%) | 110 (10%) |
Insurance | ||||||
Private | 25,775,370 (35%) | 3,389,040 (45%) | 339,900 (47%) | 2020 (17%) | 480 (26%) | 330 (31%) |
Medicare | 7 7,598,120 (10%) | 1,618,980 (22%) | 184,940 (26%) | 580 (5%) | 300 (16%) | 210 (20%) |
Medicaid | 6,094,580 (8%) | 1,292,880 (17%) | 149,690 (21%) | 530 (4%) | 160 (9%) | 110 (10%) |
Self pay | 4,904,960 (7%) | 806,110 (11%) | 40,410 (6%) | 160 (1%) | 50 (3%) | 30 (3%) |
Unknown | 6,157,570 (8%) | 604,540 (8%) | 33,340 (5%) | 180 (1%) | 60 (3%) | 40 (4%) |
